Ambient Biosciences

Ambient is developing novel biopreservation technologies for the stabilization of a variety of biopharmaceuticals including proteins, nucleic acids, viruses and cells. The technology is broadly applicable and we are currently evaluating opportunities within the analytical testing, diagnostic testing and human medicine markets with the aim of global commercialization and elimination of cold-chain requirements. Ultimately, Ambient desires that our technology has a strong social impact by enabling the delivery of life-saving medicines to regions lacking the critical infrastructure required for medical storage.